Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Percutaneous mitral balloon valvotomy.

Mohamed Eid Fawzy1

  • 1Adult Cardiology, King Faisal Heart Institute, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. fawzy100@hotmail.com

Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|January 27, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Left atrial structural and functional remodeling following balloon mitral valvuloplasty.

The international journal of cardiovascular imaging·2020
Same author

Impact of balloon mitral valvuloplasty on left ventricular rotational deformation: Magnetic Resonance Imaging follow up study.

The international journal of cardiovascular imaging·2020
Same author

Mitral balloon valvuloplasty.

Journal of the Saudi Heart Association·2013
Same author

Long-term results up to 19 years of mitral balloon valvuloplasty.

Asian cardiovascular & thoracic annals·2009
Same author

Long-term (up to 18 years) clinical and echocardiographic results of mitral balloon valvuloplasty in 531 consecutive patients and predictors of outcome.

Cardiology·2009
Same author

Twenty-two years of follow-up results of balloon angioplasty for discreet native coarctation of the aorta in adolescents and adults.

American heart journal·2008
Same journal

Current Advances and Navigating the Complexities of SVG-PCI.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
Same journal

Association of Hospital Volume With Outcomes of Pulmonary Embolism in the United States.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
Same journal

A Stepwise Approach to Coronary Bifurcation Stenting: Enhancing Safety and Efficacy With Modified Jailed Balloon Techniques.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
Same journal

Real-World Performance and Mid-Term Durability of the Myval Transcatheter Heart Valve in Patients Undergoing Transcatheter Aortic Valve Replacement.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
Same journal

A Randomized Controlled Trial Comparing the TruSteer and FXD Double Curve Delivery Systems for Left Atrial Appendage Occlusion With the Watchman FLX Pro Device-The GUIDE-LAAO Study.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
Same journal

Long-Term Trends in Cardiac Erosion After Transcatheter Closure of Atrial Septal Defects With the Amplatzer Septal Occluder.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
See all related articles

Percutaneous mitral balloon valvotomy (PMBV) is a safe and effective treatment for severe mitral stenosis. Favorable mitral morphology significantly improves long-term outcomes and reduces restenosis rates.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Percutaneous mitral balloon valvotomy (PMBV) was developed in 1984 as an alternative to surgical mitral commissurotomy.
  • PMBV is the preferred treatment for severe, pliable rheumatic mitral stenosis (MS).
  • Patient selection and procedural experience have improved PMBV outcomes and reduced complication rates.

Purpose of the Study:

  • To review the efficacy and safety of PMBV for severe mitral stenosis.
  • To analyze complication rates, restenosis rates, and long-term survival after PMBV.
  • To discuss the impact of PMBV on associated cardiac conditions and its application in specific patient groups.

Main Methods:

  • Review of existing literature and reported complication rates.

Related Experiment Videos

  • Analysis of long-term follow-up data, including restenosis-free and event-free survival.
  • Evaluation of hemodynamic results and effects on secondary cardiac conditions.

    • Main Results:

    • PMBV exhibits low complication rates: mortality (0-0.5%), cerebral accident (0.5-1%), and MR requiring surgery (1.6-3%).
    • Restenosis rates vary (4-70%), but favorable mitral morphology is associated with significantly higher 10 and 15-year restenosis-free survival (85-65%) and event-free survival (88-66%).
    • PMBV demonstrates comparable hemodynamic results to surgical commissurotomy.

    Conclusions:

    • PMBV is a safe and effective treatment for severe mitral stenosis with favorable long-term outcomes.
    • Patient selection, particularly favorable mitral morphology, is crucial for optimizing results and minimizing restenosis.
    • The review addresses PMBV's effects on pulmonary hypertension, tricuspid regurgitation, and its use in children, pregnancy, and restenosis management.